In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is ...

The Health Ministry has said there are no plans to ban Ranitidine despite concerns over NDMA impurities linked to certain ...

At present, there is no proposal to prohibit the manufacture, distribution and sale of Ranitidine, a medication used to ...

Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to ...

The Indian government currently has no plans to ban Ranitidine, a stomach acid reducer, despite international concerns about impurities. Actions include testing and communication with drug ...

India’s Ministry of Health has taken no steps to stop other pharmaceutical companies from continuing to manufacture and sell ...

NDMA is classified as a probable human carcinogen ... Currently, there is no evidence that medicines containing this type of impurity have caused any harm to patients, say experts.

It follows concern in several countries over the presence of impurities in Zantac and other ... review the presence of N-nitrosodimethylamine (NDMA) in medicines containing the drug ranitidine.